Indefinite Delivery Contract SPE2DR25D9988

The Defense Logistics Agency (DLA) awarded a single-award Indefinite Delivery Contract (IDC) to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a comprehensive range of pharmaceutical products and medical supplies to support the medical needs of military healthcare facilities worldwide. The $499,999,999 IDC, which runs through November 2026, enables DLA to issue firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

This IDC is part of DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) solicitation, which aims to establish multiple regional prime vendor contracts to provide worldwide pharmaceutical support to the Department of Defense, United States Coast Guard, and other government agencies. The PPV-G GEN V contracts, valued at an estimated $30.3 billion, will have a 30-month base period and three 30-month option periods, with awards made to the responsive and responsible offerors providing the lowest overall distribution fees.